📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Effect of SMN Gene Dosage on ALS Risk and Disease Severity. (2021)

First Author: Moisse M

Attributed to: JPND Biological Resource Analysis to Identify New MEchanisms and phenotypes in Neurodegenerative Diseases (BRAIN-MEND) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ana.26009

PubMed Identifier: 33389754

Publication URI: http://europepmc.org/abstract/MED/33389754

Type: Journal Article/Review

Volume: 89

Parent Publication: Annals of neurology

Issue: 4

ISSN: 0364-5134